Management of breast cancer with hormones and drugs.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000032:analysis / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008408:Mastectomy; D008593:Menopause; D010052:Ovariectomy; D011182:Postoperative Care; D011379:Prognosis; D011897:Random Allocation; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D013629:Tamoxifen / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D004966:Estrogens, Conjugated (USP); D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D013629:Tamoxifen